THENA Capital is supporting MedTech high growth companies that create transformative health experiences. Fund TCX-1 is focused on early stage digital and fast-tracked devices, backing businesses addressing key need spaces across care delivery, patient support, and medical product verticals, from chronic conditions, to women’s health, oncology, and mental health.

THENA Capital aims to change the face of early stage medical technology investment through deep sector and commercialisation expertise.

THENA Capital

Org chart

Teams

Offices